IP Library › Granted Patent US 8,574,616
Granted Patent B2
US 8,574,616 · App. 12/792,510 · Granted Nov 5, 2013

Implant and method for manufacturing same

Inventors: Ullrich Bayer (Admannshagen-Bargeshagen, DE); Claus Harder (Uttenreuth, DE); Elisabeta Burean (Erlangen, DE)
Assignee: BIOTRONIK VI Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,574,616
App. No.
12/792,510
Granted
Nov 5, 2013
Kind
B2
Abstract

The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. The following manufacturing method is provided for promotion of the anti-inflammatory effect of the implant: (i) providing the body of the implant; (ii) producing an at least partially closed pore structure in a portion of the structure of the implant body close to the surface; and (iii) incorporating NO X into the cavities of the pore structure. Also described is an implant manufactured in this manner.

Claims (16)

1. A method for manufacturing a vascular implant, having a body containing metallic material comprising the following steps:

i) providing the body of the implant;

ii) producing an at least partially closed pore structure in a portion of the structure of the implant body close to the surface, comprising a reducing step followed by an annealing step in an oxidizing atmosphere, wherein the pore structure comprises microscopic structures having a diameter of less than 1 μm; and

iii) incorporating NO x into the cavities of the pore structure.

2. The method according to claim 1 , wherein the reducing step comprises heat treatment of the implant body in a carbon-containing atmosphere.

3. The method according to claim 1 , wherein the NO x is incorporated into the pore structure by applying a gauge pressure of at least 5 bar or at least 8 bar.

4. The method according to claim 1 , wherein after step iii) the implant body is coated, at least on a portion of its surface, with a polymer.

5. The method according to claim 1 , wherein the body of the implant is greater than 90% by weight iron or greater than 99% by weight iron.

6. The method according to claim 1 , wherein the pore structure has a maximum depth of 15 μm.

7. The method according to claim 6 , wherein the pore structure has a depth between 10 μm to 15 μm.

8. The method according to claim 1 , wherein the step of producing at least one partially closed pore structure further comprises a vacuum annealing step after oxidation from the oxidizing atmosphere.

9. The method according to claim 8 , wherein the reducing step, annealing step, vacuum annealing step and step of incorporating NO x is performed in a same treatment chamber.

10. The method according to claim 1 , wherein the reducing step, annealing step and step of incorporating NO x is performed in a same treatment chamber.

11. The method according to claim 1 , wherein the vascular implant is an intraluminal endoprosthesis.

12. The method according to claim 1 , wherein the implant comprises an iron alloy.

13. The method according claim 4 , wherein the polymer is selected from the group consisting of magnesium stearate, parylene, and a pharmaceutically active substance.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2010
From: BAYER, ULLRICH; HARDER, CLAUS, DR.; BUREAN, ELISABETA
To: BIOTRONIK VI PATENT AG
Reel/Frame 024475/0267 →
Continuity (2)
Provisional Application 61223414 · Jul 7, 2009
Related Publication 20110009952A1 · Jan 13, 2011